- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ 10.5572 ↑ 0.42%
[as on 14 November, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| DSP Nifty Healthcare Index Fund - Direct- Growth | - | 0.42% | 1.48% | 1.27% | 1.47% | - | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.32% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.68% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Quantity | Qty change % |
|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 17.67% | 14328 | +4.84% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 8.89% | 7647 | +7.27% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 8.71% | 10107 | +7.29% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 7.87% | 1374 | +7.26% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 7.84% | 8283 | +7.32% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.60% | 1727 | +7.27% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 5.31% | 7085 | +7.27% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.86% | 3289 | +7.31% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.96% | 1422 | +7.24% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.44% | 5282 | +6.47% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.21% | 766 | +12.32% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.19% | 3802 | +7.25% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 3.09% | 2047 | +7.23% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.90% | 1537 | +7.33% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 2.58% | 3396 | +7.30% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 2.15% | 8166 | +7.26% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.96% | 1890 | +7.26% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.61% | 71 | +7.58% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 1.24% | 2579 | +7.37% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.24% | 8402 | - |
Debt
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
DSP Nifty Healthcare Index Fund - Direct- Growth - 30 days NAV history
| Date | NAV |
|---|
| 14 November, 2025 | 10.5572 |
| 13 November, 2025 | 10.5129 |
| 12 November, 2025 | 10.4943 |
| 11 November, 2025 | 10.4085 |
| 10 November, 2025 | 10.4162 |
| 7 November, 2025 | 10.4028 |
| 6 November, 2025 | 10.431 |
| 4 November, 2025 | 10.4823 |
| 3 November, 2025 | 10.5327 |
| 31 October, 2025 | 10.4318 |
| 30 October, 2025 | 10.5251 |
| 29 October, 2025 | 10.5997 |
| 28 October, 2025 | 10.531 |
| 27 October, 2025 | 10.551 |
| 24 October, 2025 | 10.5517 |
| 23 October, 2025 | 10.6393 |
| 20 October, 2025 | 10.6505 |
| 17 October, 2025 | 10.555 |
| 16 October, 2025 | 10.4762 |
| 15 October, 2025 | 10.4369 |
| 14 October, 2025 | 10.4251 |
| 13 October, 2025 | 10.4706 |
| 10 October, 2025 | 10.4675 |
| 9 October, 2025 | 10.3621 |
| 8 October, 2025 | 10.253 |
| 7 October, 2025 | 10.302 |
| 6 October, 2025 | 10.2763 |
| 3 October, 2025 | 10.1461 |
| 1 October, 2025 | 10.1681 |
| 30 September, 2025 | 10.0416 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of DSP Nifty Healthcare Index Fund - Direct- Growth?
The latest NAV of DSP Nifty Healthcare Index Fund - Direct- Growth is 10.5572 as on 14 November, 2025.